the management of Huntington's disease

By  

PRACTICAL NEUROLOGY, Vol. 4, Iss. 4, 2004-08 ,pp. : 204-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mitochondrial Aconitase is a Transglutaminase 2 Substrate: Transglutamination is a Probable Mechanism Contributing to High-Molecular-Weight Aggregates of Aconitase and Loss of Aconitase Activity in Huntington Disease Brain

By Kim Soo-Youl   Marekov Lyuben   Bubber Parvesh   Browne Susan   Stavrovskaya Irina   Lee Jongmin   Steinert Peter   Blass John   Beal M.   Gibson Gary   Cooper Arthur  

Neurochemical Research, Vol. 30, Iss. 10, 2005-10 ,pp. : 1245-1255

Springer Publishing Company

Access to resources Recommend Favorite

Pyramidal Cell Loss in Motor Cortices in Huntington's Disease

By Macdonald V.   Halliday G.  

Neurobiology of Disease, Vol. 10, Iss. 3, 2002-08 ,pp. : 378-386

Academic Press

Access to resources Recommend Favorite

A typical Antipsychotic Induced Weight Gain: Pathophysiology and Management

By ANANTH JAMBUR   VENKATESH RAVI   BURGOYNE KARL   GADASALLI RANGAESH   BINFORD ROBERT   GUNATILAKE SARATH  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 16, Iss. 2, 2004-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite

Loss of normal huntingtin function: new developments in Huntington's disease research

By Cattaneo E.   Rigamonti D.   Goffredo D.   Zuccato C.   Squitieri F.   Sipione S.  

Trends in Neurosciences, Vol. 24, Iss. 3, 2001-03 ,pp. : 182-188

Elsevier

Access to resources Recommend Favorite